Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Cibinetide for Sale > Ara-290, EPO-Derived Peptide, Synthetic Undecapeptide, Non-Erythropoietic Peptide, Tissue-Protective Peptide, Anti-inflammatory Peptide, Research Pept
Ara-290, EPO-Derived Peptide, Synthetic Undecapeptide, Non-Erythropoietic Peptide, Tissue-Protective Peptide, Anti-inflammatory Peptide, Research Pept buy - large image1
Ara-290, EPO-Derived Peptide, Synthetic Undecapeptide, Non-Erythropoietic Peptide, Tissue-Protective Peptide, Anti-inflammatory Peptide, Research Pept buy - image1
Ara-290, EPO-Derived Peptide, Synthetic Undecapeptide, Non-Erythropoietic Peptide, Tissue-Protective Peptide, Anti-inflammatory Peptide, Research Pept buy - image2
Ara-290, EPO-Derived Peptide, Synthetic Undecapeptide, Non-Erythropoietic Peptide, Tissue-Protective Peptide, Anti-inflammatory Peptide, Research Pept buy - image3
Ara-290, EPO-Derived Peptide, Synthetic Undecapeptide, Non-Erythropoietic Peptide, Tissue-Protective Peptide, Anti-inflammatory Peptide, Research Pept buy - image4
Ara-290, EPO-Derived Peptide, Synthetic Undecapeptide, Non-Erythropoietic Peptide, Tissue-Protective Peptide, Anti-inflammatory Peptide, Research Pept buy - image5
Ara-290, EPO-Derived Peptide, Synthetic Undecapeptide, Non-Erythropoietic Peptide, Tissue-Protective Peptide, Anti-inflammatory Peptide, Research Pept buy - image6

Ara-290, EPO-Derived Peptide, Synthetic Undecapeptide, Non-Erythropoietic Peptide, Tissue-Protective Peptide, Anti-inflammatory Peptide, Research Pept

TDS 24 Inquiries

Unit Price:

$76/UNIT FOB

Get Latest Price
CAS No.:

1208243-50-8

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Hongkong

Brand:

Novio

Packaging:

10mg*10vials

Sample Available:

Yes

Price valid (until):

2026-10-21

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Peptides,Cosmetic Raw Materials,Pharmaceutical Intermediates

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    WhatsApp +852 9339 8574
    Ara-290 is a synthetically engineered undecapeptide derived from a specific functional fragment of erythropoietin, belonging to the family of derivative bioactive peptides. Its design retains the activity characteristics associated with tissue protection while eliminating the hematopoietic functions of erythropoietin, thereby achieving a profile characterized by "focused protection and specific action." This design grants Ara-290 unique value in the fields of tissue protection and functional maintenance research; it distinguishes the peptide from the intact hormone, making it a valuable subject for studying functional differentiation within peptides.

    In terms of its mechanism of action, Ara-290 primarily functions in tissue protection and the modulation of inflammation. When the body encounters various stressors and injuries, it must initiate a series of protective and reparative processes to maintain normal tissue function. Ara-290 participates in regulating signaling pathways associated with tissue protection, helping to buffer tissues against adverse impacts, while also modulating inflammatory processes to help stabilize the tissue microenvironment. This dual regulatory mechanism—combining protection with anti-inflammatory action—offers unique specificity for research into tissue function maintenance and reflects a design philosophy that prioritizes functional specificity.

    Ara-290 demonstrates significant value in the realm of tissue protection. Throughout prolonged operation, body tissues face challenges from various internal and external factors that can adversely affect their function. By participating in regulatory processes linked to tissue protection, Ara-290 helps preserve structural integrity and functional stability, thereby mitigating damage caused by adverse factors. Research indicates that the effects of Ara-290 are often associated with improved tissue status, highlighting its potential to support the maintenance of tissue function. This mechanism—addressing protection at the source—gives it unique significance in the study of tissue function.

    Ara-290 also holds substantial research value regarding the modulation of inflammation. While inflammation is a natural response to stimuli and injury, excessive or prolonged inflammation can increase the burden on tissues and impair normal function. Ara-290 modulates inflammation-related processes, helping to alleviate overactive inflammatory responses and stabilize the tissue microenvironment, thereby creating favorable conditions for normal tissue function. This "soothing rather than suppressive" mode of regulation gives it unique value in research regarding functional maintenance and reflects a more nuanced understanding of inflammation modulation.

    In terms of application characteristics, Ara-290—a synthetic undecapeptide—offers distinct advantages: a well-defined structure, specific action, and controllable purity. Designed to exclude hematopoietic activity, its mechanism focuses specifically on tissue protection and inflammation modulation, demonstrating clear targeting capabilities. Furthermore, its mature synthesis process ensures product standardization and consistency, facilitating systematic research and development. These attributes—specificity, clarity, and controllability—make it highly suitable for tissue-protection research and provide a foundation for further in-depth exploration.

    Regarding safety, it is essential to view the current status of Ara-290 objectively. As a research-grade peptide, it is primarily used in laboratory studies, investigations into tissue protection, and related application development; it has not yet undergone the comprehensive approval and market launch processes required for a fully commercialized product. Its observed effects stem largely from specific experimental conditions, with outcomes closely tied to factors such as dosage and individual physiological status. Consequently, any research or application must be grounded in thorough understanding and standardized assessment, adhering to scientific principles to avoid indiscriminate use. Research teams continue to conduct evaluations to refine the understanding of its mechanisms and effects.

    From an industry perspective, Ara-290 represents a research direction focused on "achieving specific regulation through functional differentiation." Its approach—combining functional fragments of natural hormones with modern synthetic peptide technology—offers a fresh perspective on bioactive peptide research. Unlike intact hormones with broad-spectrum effects, Ara-290 aligns with the modern research emphasis on precision, characterized by specific action, clear targeting, and focused functionality. As research into peptide functional differentiation deepens, the potential value of Ara-290 in areas such as tissue protection and inflammation modulation is likely to be further evaluated and realized.

    Naturally, there is still much to explore regarding Ara-290. Questions such as inter-individual variability in response, long-term performance, and interactions with other bioactive substances remain to be addressed in future studies. Given that tissue protection and inflammation regulation involve the complex coordination of multiple mechanisms, further evidence is required to fully elucidate the specific role Ara-290 plays in these processes. Only through thorough research and the establishment of a robust body of evidence can its application value and prospects be effectively assessed; this reflects the fundamental principles of scientific inquiry—namely, a step-by-step approach that prioritizes evidence.

    Overall, Ara-290 demonstrates unique value in the field of functional maintenance research, owing to its specialized functions in tissue protection and inflammation modulation, as well as its well-defined structure, focused mechanism of action, and controllable purity. It serves not only as a significant subject for understanding the functional differentiation of peptides but also offers a highly promising avenue for exploring gentle yet precise methods of tissue protection. By facilitating tissue protection, mitigating inflammatory responses, and maintaining functional stability, Ara-290 opens up new research perspectives and provides a vital reference and foundation for the future development of related applications.

    Items Specifications
    Product Name ARA-290
    CAS No 1208243-50-8
    Appearance White powder
    Purity 99.0%
    Specification size 10mg/vial,10vials/box
    Shop Ara-290, EPO-Derived Peptide, Synthetic Undecapeptide, Non-Erythropoietic Peptide, Tissue-Protective Peptide, Anti-inflammatory Peptide, Research Pept-Detailed Image 1
    Shop Ara-290, EPO-Derived Peptide, Synthetic Undecapeptide, Non-Erythropoietic Peptide, Tissue-Protective Peptide, Anti-inflammatory Peptide, Research Pept-Detailed Image 2
    Shop Ara-290, EPO-Derived Peptide, Synthetic Undecapeptide, Non-Erythropoietic Peptide, Tissue-Protective Peptide, Anti-inflammatory Peptide, Research Pept-Detailed Image 3
    Shop Ara-290, EPO-Derived Peptide, Synthetic Undecapeptide, Non-Erythropoietic Peptide, Tissue-Protective Peptide, Anti-inflammatory Peptide, Research Pept-Detailed Image 4
    Shop Ara-290, EPO-Derived Peptide, Synthetic Undecapeptide, Non-Erythropoietic Peptide, Tissue-Protective Peptide, Anti-inflammatory Peptide, Research Pept-Detailed Image 5
    Shop Ara-290, EPO-Derived Peptide, Synthetic Undecapeptide, Non-Erythropoietic Peptide, Tissue-Protective Peptide, Anti-inflammatory Peptide, Research Pept-Detailed Image 6
    Shop Ara-290, EPO-Derived Peptide, Synthetic Undecapeptide, Non-Erythropoietic Peptide, Tissue-Protective Peptide, Anti-inflammatory Peptide, Research Pept-Detailed Image 7
    Shop Ara-290, EPO-Derived Peptide, Synthetic Undecapeptide, Non-Erythropoietic Peptide, Tissue-Protective Peptide, Anti-inflammatory Peptide, Research Pept-Detailed Image 8
    Shop Ara-290, EPO-Derived Peptide, Synthetic Undecapeptide, Non-Erythropoietic Peptide, Tissue-Protective Peptide, Anti-inflammatory Peptide, Research Pept-Detailed Image 9
    Shop Ara-290, EPO-Derived Peptide, Synthetic Undecapeptide, Non-Erythropoietic Peptide, Tissue-Protective Peptide, Anti-inflammatory Peptide, Research Pept-Detailed Image 10
    ECHEMI Editorial Reference
    Cibinetide, also known as ARA-290, is a synthetic 11-mer peptide that binds the tissue-protective receptor. ARA290 inhibits high glucose-induced apoptosis of NRK-52E cells. Cibinetide Protects Isolated Human Islets in a Stressful Environment and Improves Engraftment in the Perspective of Intra Portal Islet Transplantation. Cibinetide Improves Corneal Nerve Fiber Abundance in Patients With Sarcoidosis-Associated Small Nerve Fiber Loss and Neuropathic Pain. ARA 290 relieves pathophysiological pain by targeting TRPV1 channel: Integration between immune system and nociception.
    Research & Reference Note

    Ara-290, EPO-Derived Peptide, Synthetic Undecapeptide, Non-Erythropoietic Peptide, Tissue-Protective Peptide, Anti-inflammatory Peptide, Research Pept is listed on ECHEMI for industrial / laboratory sourcing. This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

    Disclaimer: This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

    Reviewed by ECHEMI Scientific Review - Platform editorial review for research chemicals

    Certificates
    • Ara-290, EPO-Derived Peptide, Synthetic Undecapeptide, Non-Erythropoietic Peptide, Tissue-Protective Peptide, Anti-inflammatory Peptide, Research Pept Certificates 1 TDS

    Basic Info
    Product Name:

    Cibinetide

    Other Name:

    ARA-290 (Cibinetide);ARA290, >98%;ARA290,Cibinetide, >98%;ARA290;WZTIQQBMSJTRBR-MUZUOSMHSA-N;ara290/Poziotinib;L-Serine, 5-oxo-L-prolyl-L-α-glutamyl-L-glutaminyl-L-leucyl-L-α-glutamyl-L-arginyl-L-alanyl-L-leucyl-L-asparaginyl-L-seryl-;ARA-290(Cibinetide) acetate

    CAS No.:

    1208243-50-8

    Molecular Formula:

    C51H84N16O21

    InChIKeys:

    WZTIQQBMSJTRBR-WYKNNRPVSA-N

    Molecular Weight:

    1257.31

    EC Number:

    200-001-8

    Color/Form:

    White to off-white

    Characteristics
    Density:

    1.56±0.1 g/cm3(Predicted)

    PKA:

    2.90±0.10(Predicted)

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Peptides,Cosmetic Raw Materials,Pharmaceutical Intermediates

    Location:

    Room 1359, Room 103, Building Jia 19, Jixiang Garden, Tongzhou District, Beijing

    Year of Establishment:

    2026

  • Inquiry History
    24 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Factory Supply 99% Purity Ara 290 Peptides Raw Lyophilized Powder CAS 1208243-50-8

    1 G Oct 29, 2023
    United States

    Ara 290

    100 MG Aug 4, 2026
    United States

    ARA-290 10mg

    100 PCS Apr 17, 2026
    United States

    ARA-290

    10 MT May 10, 2024
    Denmark

    Cibinetide

    5 G Feb 11, 2024
    Lithuania

    ARA 290

    10  Nov 28, 2023
    United States

    ARA-290

    15 MG Aug 3, 2026
    United States

    ARA 290

    1 G Apr 13, 2026
    United States

    ARA-290 Peptide

    1 G Feb 6, 2026
    United States

    ARA-290

    10 PCS Nov 15, 2025
    Thailand

    Cibinetide

    200 KG May 10, 2025
    Lithuania

    ARA 290

    60  Nov 28, 2023
    Philippines

    I am looking for Ara 290 100 vials

    30 MT Aug 5, 2026
    United States

    Ara-290

    20 MG Jul 20, 2026
    United States

    ARA 290

    1 KG Jun 15, 2026
    Belgium

    ARA290

    1 KG May 20, 2026
    United States

    Reta

    60  May 4, 2026
    United States

    ARA-290 Lyophilized

    800 MG Apr 17, 2026
    United States

    Ara290

    1 G Apr 17, 2026
    Nigeria

    Snap 8

    100 PCS Apr 10, 2026
    • 1
    • 2
    • Go to Page Go
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.